TIDI Products to Inform on Eye Infection Reduction at APIC 2014

Potentially life-threatening infectious pathogens transfer via conjunctiva; risk of eye-related infection underrated; most healthcare settings put staff at risk; protocols and solutions key to compliance and risk reduction.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

TIDIShield Grab ‘n Go™ Eye Shields – Flexible, Single-Use Eyewear

Staff exposed to bodily fluids, aerosol droplets, or other potentially contaminated fluids…and those who track contact incidents…will benefit from learning more.

Neenah, WI (PRWEB) June 06, 2014

Seventy-three percent of OR nurses and clinicians report receiving direct contamination of the eye during the course of clinical care.[1] At the 41st Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC), TIDI Products, LLC, a leading manufacturer of clinically differentiated, single-use infection-prevention products, will exhibit solutions designed to reduce eye splash incidents and associated infections.

Infection transmission via eye conjunctiva is proven. Often contamination occurs without an apparent event and risk remains. In a recent study, seventy-five percent of reusable eyewear pieces tested positive for contamination post decontamination.[2] Risks include conjunctivitis, herpes, erythema, virus, flu, illness, hepatitis, HIV, even death. With regulatory ambiguity regarding eyewear use, the risk to worker safety—and impact on infection-prevention efforts—is underrated. Enhanced eyewear compliance protects healthcare worker eyes and reduces cross-contamination and infection-transmission risks. Staff exposed to bodily fluids, aerosol droplets, or other potentially contaminated fluids and those who track contact incidents will benefit from learning more.

TIDI Products invites APIC 2014 attendees to visit Booth #363 for clinical information, a free solution sample, and to learn more about a new process improvement program for reducing the incidence of eye splash and contamination. TIDI Products also will host a free post-APIC webinar presenting detailed clinical information on ineffective eyewear protocol risks and eye-splash incident reduction recommendations. The webinar features Victor R. Lange, MSPH, CRC, author of an April 2014 clinical study report published in the American Journal of Infection Control. To register for the free webinar and to learn how to reduce eye-related infections, visit go.tidiproducts.com/APIC2014.

About TIDI Products, LLC

TIDI Products is a leading manufacturer of clinically differentiated, single-use infection-prevention products. The company develops simple and innovative disposable technologies to protect healthcare workers and patients from contamination as well as to improve safety and outcomes. The Company’s products, including TIDIShield Disposable Eye and Face Shields, dispensers, and other personal protective equipment (PPE), help reduce contact and cross contamination in healthcare environments. TIDI Products is headquartered in Neenah, Wisconsin. For more information visit: http://www.tidiproducts.com.

###

Media Contact:

Brian Wilt
VP, Innovation and Product Development
TIDI Products
920.751.4308, bwilt(at)TIDIProducts(dot)com

[1] 2014 survey of 600+ Association of periOperative Registered Nurses (AORN) Surgical Conference participants.

[2] Lange VR, “Eyewear contamination levels in the operating room: Infection Risk,” Am J Infect Control. 2014 Apr; 42(4):446-447.


Contact

Attachments